When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EIDX - BridgeBio Pharma: Diversified Pipeline Makes It A Long-Term Buy
Eidos Therapeutics Inc.
Shares of BridgeBio Pharma (BBIO) are currently up 75% from IPO pricing of $17 per share in late June (a bullish sign). To be fair, shares actually opened for trading at roughly $30 and so have relatively flat performance for investors who bought on the open market.
I was originally attracted to the company due to its unique model of drug development (seeding early stage programs which are headed up by experts in respective fields or indications being pursued, less of the bureaucracy typically found in larger pharmaceutical firms). As the stock is